Need professional-grade analysis? Visit stockanalysis.com
$17.16B
18.87
4,352
5.06%
Jiangzhong Pharmaceutical Co Ltd (600750) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY26.96, down 1.17% from the previous close.
Over the past year, 600750 has traded between a low of CNY21.21 and a high of CNY27.28. The stock has gained 16.2% over this period. It is currently 27.1% above its 52-week low.
Jiangzhong Pharmaceutical Co Ltd has a market capitalization of $17.16B, with a price-to-earnings ratio of 18.87 and a dividend yield of 5.06%.
China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, fritillaria and loquat capsules, bezoar and snake gallbladder fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nourishing, tonics, rehabilitation nutrition, gastrointestinal health, and liver health products. In addition, the company offers prescription drugs comprising traditional Chinese medicine products, which includes Shenbao capsules, Paishi granules, Huangba Shengmai drink, Bazhen Yimu capsules; chemical medicine products, such as lumbrokinase enteric-coated capsules, Rabeprazole sodium enteric-coated tablets, chloroprocaine hydrochloride, etc.; and medicinal materials which includes codonopsis pilosula. The company was formerly known as Jiang Zhong Pharmaceutical Co.,Ltd and changed its name to China Resources Jiangzhong Pharmaceutical Co.,Ltd in January 2025. China Resources Jiangzhong Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Nanchang, China.
Side-by-side comparison against top Healthcare peers.